Biotage AB (publ)
BITGFOTCHealthcare
$15.01
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$18.52
52W Low$11.5
Biotage AB (publ) (BITGF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BITGF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2025Report Date: Apr 24, 2025EPS Actual
$0.00
Est. $0.02 · -77.2%
Revenue
$0.04B
Est. $0.04B · -5.5%
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Apr 24, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
BITGF reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Apr 21, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Feb 19, 2026 | $0.12 | — | — | — | $0.05B | — |
| ◌ Q4 FY2025 | Oct 23, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 6, 2025 | — | — | — | — | $0.39B | — |
| ▼ Q2 FY2025 | Apr 24, 2025 | $0.02 | $0.00 | -77.2% | $0.04B | $0.04B | -5.5% |
| ▲ Q1 FY2025 | Feb 19, 2025 | $0.14 | $0.18 | +23.2% | $0.05B | $0.06B | -12.0% |
| ▼ Q4 FY2024 | Oct 23, 2024 | $0.07 | $0.05 | -16.7% | $0.05B | $0.05B | -3.4% |
| ▼ Q3 FY2024 | Jul 16, 2024 | $0.06 | $0.06 | -7.1% | $0.05B | $0.05B | +2.7% |
Q2 FY2026
Apr 21, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 19, 2026
EPS Actual
—
EPS Est.
$0.12
EPS Surpr.
—
Revenue
—
Q4 FY2025
Oct 23, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 6, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 24, 2025Miss
EPS Actual
$0.00
EPS Est.
$0.02
EPS Surpr.
-77.2%
Revenue
$0.04B
Q1 FY2025
Feb 19, 2025Beat
EPS Actual
$0.18
EPS Est.
$0.14
EPS Surpr.
+23.2%
Revenue
$0.05B
Q4 FY2024
Oct 23, 2024Miss
EPS Actual
$0.05
EPS Est.
$0.07
EPS Surpr.
-16.7%
Revenue
$0.05B
Q3 FY2024
Jul 16, 2024Miss
EPS Actual
$0.06
EPS Est.
$0.06
EPS Surpr.
-7.1%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $1.11 | $1.11 | $1.11 | 1 |
| Q3 FY2025 | $0.88 | $0.88 | $0.88 | 1 |
| Q2 FY2025 | $0.69 | $0.69 | $0.69 | 1 |
| Q1 FY2025 | $0.22 | $0.22 | $0.22 | 1 |
| Q4 FY2024 | $1.60 | $1.60 | $1.60 | 1 |
| Q3 FY2024 | $0.67 | $0.67 | $0.68 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.5B | $0.5B | $0.5B | 1 |
| Q3 FY2025 | $0.5B | $0.5B | $0.5B | 1 |
| Q2 FY2025 | $0.5B | $0.5B | $0.5B | 1 |
| Q1 FY2025 | $0.4B | $0.4B | $0.4B | 2 |
| Q4 FY2024 | $0.6B | $0.7B | $0.7B | 2 |
| Q3 FY2024 | $0.5B | $0.5B | $0.5B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2025 | Apr 24, 2025 | -77.2% | $11.50 | $11.50 | +0.00% |
| ▲ Q1 FY2025 | Feb 19, 2025 | +23.2% | $13.00 | $13.00 | +0.00% |
| ▼ Q4 FY2024 | Oct 23, 2024 | -16.7% | $16.45 | $16.00 | -2.74% |
| ▼ Q3 FY2024 | Jul 16, 2024 | -7.1% | $15.69 | $15.69 | +0.00% |
| ▼ Q2 FY2024 | Apr 25, 2024 | -23.2% | $16.87 | $14.63 | -13.28% |
| ▲ Q1 FY2024 | Feb 15, 2024 | +104.5% | $12.00 | $12.00 | +0.00% |
| ▼ Q3 FY2023 | Sep 29, 2023 | -22.6% | $9.65 | $9.65 | +0.00% |
| ▼ Q2 FY2023 | Jun 29, 2023 | -38.6% | $12.00 | $12.00 | +0.00% |
Q2 FY2025+0.00%
Report Date
Apr 24, 2025
EPS Beat/Miss
-77.2%
Price Before
$11.50
Price After
$11.50
Q1 FY2025+0.00%
Report Date
Feb 19, 2025
EPS Beat/Miss
+23.2%
Price Before
$13.00
Price After
$13.00
Q4 FY2024-2.74%
Report Date
Oct 23, 2024
EPS Beat/Miss
-16.7%
Price Before
$16.45
Price After
$16.00
Q3 FY2024+0.00%
Report Date
Jul 16, 2024
EPS Beat/Miss
-7.1%
Price Before
$15.69
Price After
$15.69
Q2 FY2024-13.28%
Report Date
Apr 25, 2024
EPS Beat/Miss
-23.2%
Price Before
$16.87
Price After
$14.63
Q1 FY2024+0.00%
Report Date
Feb 15, 2024
EPS Beat/Miss
+104.5%
Price Before
$12.00
Price After
$12.00
Q3 FY2023+0.00%
Report Date
Sep 29, 2023
EPS Beat/Miss
-22.6%
Price Before
$9.65
Price After
$9.65
Q2 FY2023+0.00%
Report Date
Jun 29, 2023
EPS Beat/Miss
-38.6%
Price Before
$12.00
Price After
$12.00
Avg Beat Reaction+0.00%
Avg Miss Reaction-2.67%
Beat Rate2 / 8 quarters
Largest Move-13.28% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BITGF ends December
Biotage AB (publ) (BITGF) most recently reported earnings on April 24, 2025 for Q2 FY2025, posting EPS of $0.00 — missing the analyst consensus of $0.02 by -77.2%. The next BITGF earnings date is expected around September 1, 2026.
Each quarter, investors track BITGF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BITGF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BITGF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BITGF earnings · 5 questionsBiotage AB (publ)'s next earnings report is expected around September 1, 2026. BITGF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BITGF historically reports after market close (AMC).
BITGF earnings datewhen is BITGF earningsBITGF next earnings datewhen does BITGF report earningsBITGF earnings calendar
▸ Source: FMP · Biotage AB (publ) SEC filings · US GAAP · Biotage AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026